[
  {
    "ts": "2026-02-02T14:36:46+00:00",
    "headline": "Janux Therapeutics, Inc. (JANX) Faces Platform Risk Amid Lack of Durability Data on JANX007",
    "summary": "We recently compiled a list of the 20 Best Biotech Stocks Under $20 to Buy Now. The fifth stock on our list of best biotech stocks is Janux Therapeutics, Inc. TheFly reported on January 20 that Clear Street downgraded JANX to Hold from Buy and lowered the price target to $12 from $32. The firm […]",
    "url": "https://finance.yahoo.com/news/janux-therapeutics-inc-janx-faces-143646165.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "c14491fb-0cad-3fad-9978-d47de164d31f",
      "content": {
        "id": "c14491fb-0cad-3fad-9978-d47de164d31f",
        "contentType": "STORY",
        "title": "Janux Therapeutics, Inc. (JANX) Faces Platform Risk Amid Lack of Durability Data on JANX007",
        "description": "",
        "summary": "We recently compiled a list of the 20 Best Biotech Stocks Under $20 to Buy Now. The fifth stock on our list of best biotech stocks is Janux Therapeutics, Inc. TheFly reported on January 20 that Clear Street downgraded JANX to Hold from Buy and lowered the price target to $12 from $32. The firm […]",
        "pubDate": "2026-02-02T14:36:46Z",
        "displayTime": "2026-02-02T14:36:46Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/506c35d972e24e54ed3585ed5f0f8691",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Janux Therapeutics, Inc. (JANX) Faces Platform Risk Amid Lack of Durability Data on JANX007",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0xk9TdmKbL4i.6s91DFivw--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/506c35d972e24e54ed3585ed5f0f8691.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/PV6gy4F.TRxrhWQiejsU3g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/506c35d972e24e54ed3585ed5f0f8691.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/janux-therapeutics-inc-janx-faces-143646165.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/janux-therapeutics-inc-janx-faces-143646165.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JANX"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-02T13:30:00+00:00",
    "headline": "Lupin Launches Dasatinib Tablets in the United States",
    "summary": "Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced the launch of Dasatinib Tablets, 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg, in the United States, following the approval for its Abbreviated New Drug Application (ANDA) from the U.S. FDA. The product was developed in partnership with Pharmascience Inc.",
    "url": "https://finance.yahoo.com/news/lupin-launches-dasatinib-tablets-united-133000496.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "b4e334fd-d5e6-3c5e-8fa8-b935839f2d74",
      "content": {
        "id": "b4e334fd-d5e6-3c5e-8fa8-b935839f2d74",
        "contentType": "STORY",
        "title": "Lupin Launches Dasatinib Tablets in the United States",
        "description": "",
        "summary": "Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced the launch of Dasatinib Tablets, 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg, in the United States, following the approval for its Abbreviated New Drug Application (ANDA) from the U.S. FDA. The product was developed in partnership with Pharmascience Inc.",
        "pubDate": "2026-02-02T13:30:00Z",
        "displayTime": "2026-02-02T13:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/0d2424ae8b9a41b9324c931bddd820bb",
          "originalWidth": 331,
          "originalHeight": 400,
          "caption": "Lupin Logo",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/UHgWQuNU0SGZQZNAGqsZdg--~B/aD00MDA7dz0zMzE7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/0d2424ae8b9a41b9324c931bddd820bb.cf.webp",
              "width": 331,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/z_qWWXA4cc4F_TFH4zu.CQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/0d2424ae8b9a41b9324c931bddd820bb.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/lupin-launches-dasatinib-tablets-united-133000496.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/lupin-launches-dasatinib-tablets-united-133000496.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LUPIN.BO"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]